YS Biopharma Co. Ltd.

NASDAQ: YS · Real-Time Price · USD
1.02
0.09 (9.68%)
At close: May 24, 2024, 10:00 PM

YS Biopharma Revenue

YS Biopharma reported an annual revenue of $687.2M, reflecting a 36.63% growth. For the quarter ending December 31, 2023, YS Biopharma generated $164.98M in revenue.
Revenue (ttm)
687.2M
Revenue Growth
36.63%
Price / Sales Ratio
1.49
Revenue / Employee
889.01K
Employees
773
Market Cap
192.09M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Mar 31, 2023 687.2M +36.63%
Mar 31, 2022 502.95M +95.69%
Mar 31, 2021 257.02M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.